AG003SQL

105816-04-4 | (2R)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoic acid

Chemical structure of (2R)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoic acid, CAS 105816-04-4
AG003SQL
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 105816-04-4
Catalog Number AG003SQL(AGN-PC-0NW7SQ)
Chemical Name (2R)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoic acid
IUPAC Name (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
InChI InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1
InChI Key OELFLUMRDSZNSF-OFLPRAFFSA-N
MDL Number MFCD00875706
Molecular Formula C19H27NO3
Molecular Weight 317.4226
SMILES O=C(O)[C@@H](CC1=CC=CC=C1)NC([C@H]2CC[C@H](C(C)C)CC2)=O
UNII 41X3PWK4O2
Synonyms
A 4166, A-4166, A4166, AY 4166, AY-4166, AY4166, DJN 608, Fastic, N-((4-isopropylcyclohexyl)carbonyl)phenylalanine, nate-glinide, nateglinide, nateglinide, (cis,D-Phe)-isomer, nateglinide, (D-Phe)-isomer, senaglinide, Starlix, Starsis, nateglinide, 105816-04-4, Starlix, Fastic, Starsis, Trazec, AY-4166, A-4166, SDZ-DJN-608, DJN-608, DJN 608, Nateglinide [INN], UNII-41X3PWK4O2, AY 4166, AY4166, MFCD00875706, CHEMBL783, A 4166, SDZ DJN 608, 41X3PWK4O2, N-[(trans-4-Isopropylcyclohexyl)carbonyl]-D-phenylalanine, senaglinide, CHEBI:31897, SDZ-DJN 608, 105816-06-6, (-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine, N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine, (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid, DSSTox_CID_20687, DSSTox_RID_79543, DSSTox_GSID_40687, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine, trans-N-((4-(1-Methylethyl)cyclohexyl)carbonyl)-D-phenylalanine, D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-, D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-, SMR000466372, CAS-105816-04-4, nateglinida, nateglinidum, trans-N-{[4-(1-methylethyl)cyclohexyl]carbonyl}-D-phenylalanine, NCGC00095121-01, Nateglinide [USAN:USP:INN:BAN], Starsis (TN), Nateglinide(Starlix), Nateglinide, Starlix, YM-026, Nateglinide (Starlix), AC1NSKEK, Nateglinide cis Impurity, SCHEMBL22088, MLS000759500, MLS001424043, MLS003915639, MLS006011429, BIDD:GT0257, SCHEMBL303827, GTPL6833, SCHEMBL7880361, SCHEMBL9232138, ZINC9689, CHEMBL2114389, D-Phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, trans-, DTXSID9040687, SCHEMBL13753829, CHEBI:94617, Nateglinide (JP17/USAN/INN), OELFLUMRDSZNSF-BRWVUGGUSA-N, HMS2051G20, HMS2089A10, HMS2235O08, HMS3675G17, HMS3715F12, BCP28400, carboxamido)-3-phenylpropanoic acid, EBD10749, HY-B0422, n-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-d-phenylalanine, Tox21_111432, BBL033469, BDBM50344967, s2489, STK647123, AKOS005577723, AKOS015841612, AKOS015960899, Nateglinide, >=98% (HPLC), solid, Tox21_111432_1, ZINC100015346, ZINC101489663, AC-1690, CCG-100898, CS-2528, DB00731, KS-5143, MCULE-4748076858, NC00148, SB17322, NCGC00178741-03, NCGC00271534-02, NCGC00271534-03, BC204579, CPD000466372, SAM001246721, (R)-2-((1r,4R)-4-isopropylcyclohexane, AB0011153, AB2000594, TL8000218, FT-0631035, N0912, SW197528-2, C12508, D01111, K-0514, AB00639979-06, AB00639979-08, AB00639979-09, AB00639979-11, AB00639979_12, 816N044, A-4166;, A801324, A1-02996, Q-201449, N-(Trans-4-Isopropylcyclohexylcarbonyl)-D-Phenyl Alanine, n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine, (trans-4-isopropylcyclohexane-1-carbonyl)-D-phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine, Nateglinide, European Pharmacopoeia (EP) Reference Standard, ((1r,4R)-4-isopropylcyclohexane-1-carbonyl)-D-phenylalanine, 2-[(4-Isopropyl-cyclohexanecarbonyl)-amino]-3-phenyl-propionic acid, N-(4alpha-Isopropylcyclohexane-1alpha-yl)carbonyl-D-phenylalanine, Nateglinide, United States Pharmacopeia (USP) Reference Standard, (2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoic acid, (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexyl)carbonylamino]propanoic acid, (r)-2-((1r,4r)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid, (2R)-2-[[oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid, (2R)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoic acid, N-[[cis-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (Nateglinide Impurity), 105746-37-0, nate-glinide, glinate, glunate, natelide, Netaglinide, D-Nateglinide, IPCCPA, Starlix (TN), nateglinide, (D-Phe)-isomer, D06PSS, Novartis brand of nateglinide, nateglinide, (cis,D-Phe)-isomer, Nateglinide Related CoMpound C, C19H27NO3, C19-H27-N-O3, CB11566, CID5311309, CS-O-30674, N-((4-isopropylcyclohexyl)carbonyl)phenylalanine, A4166, B2198, A10629, C060142, n-{[4-(propan-2-yl)cyclohexyl]carbonyl}phenylalanine, D000077715, Nateglinide, 98%, an insulin secretagog agent - 1g 1g, (-)-n-(trans-4-isopropylcyclohexyl-1-carbonyl)-d-phenylalanine, n-(trans-4-Isopropylcylolohexylcarboxyl)-d-phenylpropylicacid, 3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited